H
Hans-Dieter Foss
Researcher at Free University of Berlin
Publications - 82
Citations - 6412
Hans-Dieter Foss is an academic researcher from Free University of Berlin. The author has contributed to research in topics: Lymphoma & Antigen. The author has an hindex of 41, co-authored 82 publications receiving 6194 citations. Previous affiliations of Hans-Dieter Foss include University of Würzburg.
Papers
More filters
Journal ArticleDOI
CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.
Harald Stein,Hans-Dieter Foss,Horst Dürkop,Theresa Marafioti,Georges Delsol,Karen Pulford,Stefano Pileri,Brunangelo Falini +7 more
TL;DR: Recent immunohistologic studies suggest that ALCLs Hodgkin-like represent either cases of tumor cell-rich classic Hodgkin disease or (less commonly) ALK(+) ALCL orALK(-) ALCL, both of which have an unfavorable prognosis.
Journal ArticleDOI
Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis
H. Schmitz,Christian Barmeyer,Michael Fromm,Norbert Runkel,Hans-Dieter Foss,Carl J. Bentzel,Ernst-Otto Riecken,Jörg-Dieter Schulzke +7 more
TL;DR: The inflamed colonic mucosa in UC has an impaired barrier function that is much more pronounced than previously assumed and an altered TJ structure contributes to this barrier defect which, because of increased back leak, can reduce net ion transport.
Journal ArticleDOI
Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription
Theresa Marafioti,Michael Hummel,Michael Hummel,Hans-Dieter Foss,Hans-Dieter Foss,Helmut Laumen,Helmut Laumen,Korbjuhn P,Korbjuhn P,Ioannis Anagnostopoulos,Ioannis Anagnostopoulos,Hetty Lammert,Hetty Lammert,Gudrun Demel,Gudrun Demel,Jan Theil,Jan Theil,Thomas Wirth,Thomas Wirth,Harald Stein,Harald Stein +20 more
TL;DR: In this paper, a single-cell study was performed on 25 patients with Hodgkin and Reed-Sternberg (HRS) disease, with and without Epstein-Barr virus infection, for the presence of gene rearrangements.
Journal ArticleDOI
Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription.
Harald Stein,Theresa Marafioti,Hans-Dieter Foss,Helmut Laumen,Michael Hummel,Ioannis Anagnostopoulos,Thomas Wirth,Gudrun Demel,Brunangelo Falini +8 more
TL;DR: Oct2 was revealed as a new and valuable marker for the identification of L&H cells and their distinction from HRS cells and the impairment of immunoglobulin transcription with a down-regulated synthesis of Oct2 and BOB.1/OBF.1 is dismissed.
Journal ArticleDOI
Intestinal Non-Hodgkin’s Lymphoma: A Multicenter Prospective Clinical Study From the German Study Group on Intestinal Non-Hodgkin’s Lymphoma
Severin Daum,Reiner Ullrich,W Heise,Bettina Dederke,Hans-Dieter Foss,Harald Stein,Eckhard Thiel,Martin Zeitz,Ernst-Otto Riecken +8 more
TL;DR: IBCL patients at stages EI and EII respond well to chemotherapy, but the prognosis and treatment of ITCL patients is unsatisfactory, according to a prospective, nonrandomized multicenter study.